Table 3.
Clinicopathological characteristics of 71 thyroid nodule patients.
| Clinicopathological characteristics | Value | PC expression | P | ||
|---|---|---|---|---|---|
| High | Low | ||||
| Gender | |||||
| male | 27 | 11 | 16 | 0.807 | |
| female | 44 | 20 | 24 | ||
| Age (Y), Mean ± SD | 44.5 ± 1.5 | ||||
| ≥55, n (%) | 20 (28.3%) | 11 | 15 | 1 | |
| <55, n (%) | 51 (71.8%) | 20 | 25 | ||
| Cytology diagnosis (71) | |||||
| PTC | 52 (73.2%) | 28 | 24 | 0.006* | |
| Benign nodule | 19 (26.3%) | 3 | 16 | ||
| Surgically diagnosed PTC (34) | |||||
| CLNM | Positive | 17 (50.0%) | 11 | 6 | 0.037* |
| Negative | 17 (50.0%) | 4 | 12 | ||
| Tumor size (mm) | ≥5, n (%) | 25 (73.5%) | 11 | 14 | 1 |
| <5, n (%) | 9 (26.5%) | 4 | 4 | ||
| Extrathyroidal extension | Positive | 16 (47.1%) | 7 | 9 | |
| Negative | 18 (52.9%) | 8 | 9 | 1 | |
| Multifocal tumor | Positive | 27 (79.4%) | 12 | 15 | 1 |
| Negative | 7 (20.6) | 3 | 3 | ||
| Bilateral distribution | Positive | 13 (38.2%) | 7 | 9 | 1 |
| Negative | 21 (61.8%) | 8 | 9 | ||
| TNM stage | I + II | 28 (82.4%) | 14 | 13 | 0.186 |
| III + IV | 6 (17.6%) | 1 | 5 | ||
PTC, papillary thyroid carcinoma; CLNM, central lymph nodal metastasis; PC, pyruvate carboxylase; TNM, tumor-node-metastasis. *P <0.05.